Stay updated on TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin

Sign up to get notified when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.
Latest website image capture
Clouds background image

Latest updates to the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Minor revision update from v3.4.1 to v3.4.2 is shown, with no visible changes to study content or page functionality. The additions/deletions are limited to the revision label and do not affect eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:26:37.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1; no substantive study information or user-facing functionality is altered. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-05T13:33:30.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page revision label now shows 'Revision: v3.3.4'; the previous 'Revision: v3.3.3' label was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-15T03:29:07.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    No significant updates to core study content detected; changes appear limited to formatting and minor wording in non-critical sections. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-08T01:26:49.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Added a new Locations section listing California as a study site. Removed the California Locations entry and the HHS Vulnerability Disclosure text, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-24T15:31:11.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The screenshots show no significant changes to core study content; only metadata such as the last update date appears to be different. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T06:19:01.000Z thumbnail image

Stay in the know with updates to TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin

Enter your email address, and we'll notify you when there's something new on the TNT Clinical Trial: Talimogene + Nivolumab + Trabectedin page.